Pasteurella multocida thymidine kinase 1 efficiently activates pyrimidine nucleoside analogs

Nucleosides Nucleotides Nucleic Acids. 2010 Jun;29(4-6):359-62. doi: 10.1080/15257771003729716.

Abstract

In the Pasteurella multocida genome only one putative deoxyribonucleoside kinase encoding gene, for thymidine kinase 1 (PmTK1), was identified. The PmTK1 gene was sub-cloned into Escherichia coli KY895 and it sensitized the host towards 2',2'-difluoro-deoxycytidine (gemcitabine, dFdC), 3'-azido-thymidine (AZT) and 5-fluoro-deoxyuridine (5F-dU). PmTK1 was over-expressed and purified with two different tags. Apparently, deoxyuridine (dU), and not thymidine (dT), is the preferred substrate. We suggest that PmTK1s could be employed as a species-specific activator of uracil-based nucleoside antibiotics.

MeSH terms

  • Antimetabolites, Antineoplastic / metabolism
  • Antimetabolites, Antineoplastic / pharmacology
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / metabolism
  • Deoxycytidine / pharmacology
  • Deoxyuridine / pharmacology
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Escherichia coli / metabolism
  • Gemcitabine
  • Microbial Sensitivity Tests
  • Pasteurella multocida / enzymology*
  • Pyrimidine Nucleosides / metabolism*
  • Pyrimidine Nucleosides / pharmacology
  • Thymidine Kinase / genetics
  • Thymidine Kinase / metabolism*
  • Zidovudine / pharmacology

Substances

  • Antimetabolites, Antineoplastic
  • Pyrimidine Nucleosides
  • Deoxycytidine
  • Zidovudine
  • Thymidine Kinase
  • thymidine kinase 1
  • Deoxyuridine
  • Gemcitabine